• Company
    • About STADA
    • Management
    • Our Corporate Culture
    • STADA worldwide
    • Company History
    • Compliance
  • Products
    • Consumer Healthcare Products
    • Specialty Pharmaceuticals
    • Generics
    • Partnerships
    • Quality at STADA
    • Adverse drug reaction report
  • Stories
  • Sustainability
    • Sustainability Report
    • Supply Chain Act
  • Investors
    • At a Glance
    • Financial Publications
    • Corporate Governance
    • IR Contact
  • Media
    • Newsroom
    • Press Releases
    • Press Photos
    • STADA Health Report
    • Social Media
    • Media Contact
  • Career
    • Purpose, Vision, and Values
    • Your Growth Journey
    • Your Benefits
    • Our Application Process
en-GB
  • DeutschDeutsch (DE-DE)
  • Company
    • About STADA
    • Management
    • Our Corporate Culture
    • STADA worldwide
    • Company History
    • Compliance
  • Products
    • Consumer Healthcare Products
    • Specialty Pharmaceuticals
    • Generics
    • Partnerships
    • Quality at STADA
    • Adverse drug reaction report
  • Stories
  • Sustainability
    • Sustainability Report
    • Supply Chain Act
  • Investors
    • At a Glance
    • Financial Publications
    • Corporate Governance
    • IR Contact
  • Media
    • Newsroom
    • Press Releases
    • Press Photos
    • STADA Health Report
    • Social Media
    • Media Contact
  • Career
    • Purpose, Vision, and Values
    • Your Growth Journey
    • Your Benefits
    • Our Application Process
  1. 2025

2025

2025
Press Releases
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013

All 2025 posts

FOLLOW US
PRODUCTS
Nizoral® Grippostad® Lunestil® Immunology Nephrology Neurology
COMPANY
About us Products Investors Media Career STADA Worldwide
GET IN TOUCH
Contact info@stada.de +49 6101 603-0 Compliance Reporting Portal ⧉
  • Conditions of Use
  • Privacy Policy
  • Imprint
  • Cookie Settings
Progenerika | © Copyright STADA Arzneimittel AG 2025